Canopy Growth takes steps to prevent another recall at newly acquired Mettrum Health

February 27, 2017 by

Canopy Growth Corporation-Tweed Marijuana Inc. Renamed CGCSmiths Falls Canopy Growth, Canada's largest publicly traded marijuana company says it has made "numerous process and personnel changes" at its newly acquired Mettrum Health operations, that will prevent a repeat of last year's product recall.

Mettrum had announced a product recall back in November before Canopy acquired the company. Canopy paid $430 million for Mettrum.

Health Canada discovered the company had used a pesticide that's not approved for use on medical cannabis.

Canopy issued an open letter telling customers that "a recall like this will never happen again."

CEO Bruce Linton said use of unregistered pest control products was "inexcusable."

His letter to Mettrum customers repeated previous assurances to analysts that Mettrum's practices would be brought in line with those at Canopy's Tweed, and Tweed Farms operations, which Linton said have never been the subject of a product recall.

Facebook
TWITTER